BCM
QTTB icon

Boxer Capital Management’s Q32 Bio QTTB Stock Holding History

Boxer Capital Management’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40.1M Buy
+3,149,310
New +$26.3M 3.02% 10

Other funds holding QTTB

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.89B AUM 55.94% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

Boxer Capital Management's QTTB Position: Q2 2026 in Review

Boxer Capital Management opened a new position in Q32 Bio (QTTB) in Q2 2026: 3,149,310 shares worth $40.1M. The stake represents 3.02% of the portfolio and ranks #10 among its holdings.

67 funds tracked by Wall St. Rank hold QTTB as of Q2 2026.

  • Boxer Capital Management held 3,149,310 shares of Q32 Bio worth $40.1M as of Q2 2026.
  • Q32 Bio was a new Boxer Capital Management position in Q2 2026.
  • Q32 Bio made up 3.02% of Boxer Capital Management's portfolio in Q2 2026, its #10 holding.
  • 67 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2026.

Based on Boxer Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.